CSIMarket
 


Ibio Inc   (IBIO)
Other Ticker:  
 

Ibio Inc 's Quick Ratio

IBIO's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth




IBIO Quick Ratio (Mar 31 2020)
III. Quarter
(Dec 31 2019)
II. Quarter
(Sep 30 2019)
I. Quarter
(Jun 30 2019)
IV. Quarter
(Mar 31 2019)
III. Quarter
Y / Y Current Liabilities Change 208.18 % 147.21 % -3.32 % 7.08 % 2.98 %
Y / Y Cash & cash equivalent Change 11.07 % -72.65 % -86.74 % -72.15 % 164.63 %
Quick Ratio MRQ 1.63 0.77 0.44 2.04 4.52
Overall Ranking # # # # #
Seq. Current Liabilities Change 30.25 % -2.57 % 123.45 % 8.68 % 4.48 %
Seq. Cash & cash equivalent Change 174.9 % 72.12 % -52.15 % -50.94 % -32.3 %



Quick Ratio third quarter 2020 Comment
Ibio Inc 's Cash & cash equivalent grew by 174.9 % in III. Quarter sequntially, faster than Current Liabilities, this led to improvement in Ibio Inc 's Quick Ratio to 1.63, Quick Ratio remained below Ibio Inc average.

Within Major Pharmaceutical Preparations industry 196 other companies have achieved higher Quick Ratio than Ibio Inc in third quarter 2020. While total ranking remained unchanged compare to previous quarter at no. .

Explain Quick Ratio?
What are IBIO Segments?
See Quick Ratio IBIO on the trailing twelve month basis
Quick Ratio third quarter 2020 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 197
Healthcare Sector # 448
Overall Market # 1064


Quick Ratio Statistics
High Average Low
10.06 4.07 0.13
(Jun 30 2016)   (Dec 31 2011)




Financial Statements
Ibio Inc 's Current Liabilities $ 6 Millions Visit IBIO's Balance sheet
Ibio Inc 's Cash & cash equivalent $ 10 Millions Visit IBIO's Balance sheet
Source of IBIO's Sales Visit IBIO's Sales by Geography




Companies with similar Quick Ratio in the quarter endingMar 31 2020, within Major Pharmaceutical Preparations Industry Quick RatioMar 31 2020 MRQ Cash & cash equivalentMar 31 2020 MRQ Current Liabilities
Dynavax Technologies Corp  4.42 $ 129.533  Millions$ 29.279  Millions
Evolus Inc   4.41 $ 99.639  Millions$ 22.613  Millions
Optinose Inc   4.34 $ 148.475  Millions$ 34.225  Millions
Anchiano Therapeutics Ltd   4.27 $ 14.009  Millions$ 3.283  Millions
Amarin Corp Plcuk  4.04 $ 546.145  Millions$ 135.308  Millions
Cormedix Inc   4.00 $ 23.208  Millions$ 5.804  Millions
Rezolute Inc   3.99 $ 14.068  Millions$ 3.530  Millions
Pacira Biosciences inc   3.97 $ 318.464  Millions$ 80.313  Millions
Acer Therapeutics Inc   3.94 $ 7.007  Millions$ 1.780  Millions
Alnylam Pharmaceuticals Inc   3.85 $ 1,304.125  Millions$ 338.791  Millions
Molecular Templates Inc   3.84 $ 104.988  Millions$ 27.309  Millions
Lipocine Inc   3.84 $ 15.583  Millions$ 4.060  Millions
Heat Biologics Inc   3.81 $ 26.445  Millions$ 6.937  Millions
Shineco Inc   3.75 $ 40.646  Millions$ 10.852  Millions
Ritter Pharmaceuticals Inc  3.72 $ 5.953  Millions$ 1.602  Millions
Intercept Pharmaceuticals inc   3.71 $ 555.680  Millions$ 149.968  Millions
Amicus Therapeutics inc   3.69 $ 338.873  Millions$ 91.714  Millions
Heron Therapeutics Inc   3.68 $ 356.346  Millions$ 96.765  Millions
Siga Technologies Inc  3.61 $ 77.377  Millions$ 21.425  Millions
Moleculin Biotech Inc   3.60 $ 11.649  Millions$ 3.235  Millions
Nektar Therapeutics  3.57 $ 1,345.882  Millions$ 377.471  Millions
Synthetic Biologics Inc   3.51 $ 10.100  Millions$ 2.876  Millions
Avadel Pharmaceuticals Plc  3.51 $ 113.483  Millions$ 32.336  Millions
Flexion Therapeutics Inc   3.51 $ 125.231  Millions$ 35.696  Millions
Biohaven Pharmaceutical Holding Company Ltd   3.51 $ 428.239  Millions$ 122.098  Millions
Concert Pharmaceuticals Inc   3.44 $ 49.065  Millions$ 14.271  Millions
Ultragenyx Pharmaceutical Inc   3.37 $ 663.278  Millions$ 196.858  Millions
Acelrx Pharmaceuticals Inc  3.35 $ 52.725  Millions$ 15.721  Millions
Spectrum Pharmaceuticals Inc  3.31 $ 177.793  Millions$ 53.698  Millions
Tetraphase Pharmaceuticals Inc  3.21 $ 26.146  Millions$ 8.144  Millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

MGC's Profile

Stock Price

MGC's Financials

Business Description

Fundamentals

Charts & Quotes

MGC's News

Suppliers

MGC's Competitors

Customers & Markets

Economic Indicators

MGC's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071